Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer

Anticancer Research

Volumn 34, Issue 12, 2014, Pages 7255-7261

  Ordu, Arif Deniz ^a   Nieder, Carsten ^b   Geinitz, Hans ^a,c   Scherer, Vera ^a   Kup, Philipp Gunther ^a   Schuster, Tibor ^d   Combs, Stephanie E ^a   Fakhrian, Khashayar ^a,c,e  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Nordland Hospital Trust   (Norway)

^c Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

^d MCGILL UNIVERSITY   (Canada)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Esophageal cancer; Neoadjuvant radiochemotherapy; PCR; Radiation dose effect.; Regression; Squamous cell carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ACUTE TOXICITY; ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; DRUG EFFICACY; DYSPHAGIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HOARSENESS; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOLOGICAL COMPLETE RESPONSE; RADIATION DOSE; RADICAL RESECTION; TREATMENT RESPONSE; ADJUVANT THERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROCEDURES; RADIATION RESPONSE; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; RADIATION DOSAGE; SURVIVAL RATE;

EID: 84918567866     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fakhrian K, Ordu AD, Lordick F, Theisen J, Haller B, Omrčen T, Molls M, Nieder C and Geinitz H: Long-Term Outcomes of Trimodality Treatment of Squamous Cell Carcinoma of Esophagus with cisplatin and/or 5-FU. More Than Twenty Years Experience at a Single Institution. Strahlenther Onkol Jul 12 [Epub ahead of print], 2014
2. Bruher BL, Becker K, Lordick F, Fink U, Sarbia M, Stein H, Busch R, Zimmermann F, Molls M, Huler H and Siewert JR: The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer 106(10): 2119-2127, 2006
3. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L and Peracchia A: Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 91(11): 2165-2174, 2001
4. Yaes RJ, Patel P and Maruyama Y: On using the linear-quadratic model in daily clinical practice. Int J Radiat Oncol Biol Phys 20(6): 1353-1362, 1991
5. Sobin LH and Wittekind CH: UICC TNM Classification of Malignant Tumor, 6th ed. New York, John Wiley &Sons Inc, 2002
6. Becker K, Mueller JD, Schuhmacher C, Ott K, Fink U, Busch R, Btcher K, Siewert JR and Huler H: Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98(7): 1521-1530, 2003
7. Saville DJ: Multiple comparison procedures-The practical solution. Am Statistician 44: 174-180, 1990
8. Siewert JR, Stein HJ and Fink U: Multimodality Therapy for Esophageal Cancer. The Oncologist 1: 210-218, 1996
9. Kranzfelder M, Schuster T, Geinitz H, Friess H and Bhler P: Meta-Analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 98(6): 768-783, 2011
10. Fakhrian K, Ordu AD, Haller B, Theisen J, Lordick F, Biof V, Molls M and Geinitz H: Cisplatin-vs. oxaliplatin-based radiosensitizing chemotherapy for squamous cell carcinoma of the esophagus: A comparison of two preoperative radiochemotherapy regimens. Strahlenther Onkol Apr 16 [Epub ahead of print], 2014
11. Suh YG, Lee IJ, Koom WS, Cha J, Lee JY, Kim SK and Lee CG: High-dose Versus Standard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal Cancer. Jpn J Clin Oncol 44(6): 534-540, 2014
12. Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD and Komaki R: Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61(3): 656-664, 2005
13. Donahue JM, Nichols FC, Li Z, Schomas DA, Allen MS, Cassivi SD, Jatoi A, Miller RC, Wigle DA, Shen KR and Deschamps C: Complete pathologic response after neoadjuvant chemo-radiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg 87: 392-399, 2009
14. Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H and Goldberg M: Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23: 4330-4337, 2005
15. Denham JW, Steigler A, Kilmurray J, Wratten C, Burmeister B, Lamb DS, Joseph D, Delaney G, Christie D, Jamieson G, Smithers BM, Ackland S and Walpole E: Relapse patterns after chemo-radiation for carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 15: 98-108, 2003
16. Burmeister BH, Smithers BM and Denham JW: Combined modality therapy for carcinoma of the oesophagus: Current status and future directions. Med J Aust 167: 349-350, 1997
17. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA and Ajani JA: Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104: 1349-1355, 2005
18. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET and Denham JW: Surgery alone vs. chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 6: 659-668, 2005
19. Dewit L: Combined treatment of radiation and cisdiamminedichloroplatinum( II): a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13: 403-426, 1987
20. Park JW, Kim JH, Choi EK, Lee SW, Yoon SM, Song SY, Lee YS, Kim SB, Park SI and Ahn SD: Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 81(3): 691-697, 2011.